{"id":2406,"date":"2025-05-11T17:41:13","date_gmt":"2025-05-11T17:41:13","guid":{"rendered":"https:\/\/beyondtheimpact.net\/?p=2406"},"modified":"2025-05-11T17:41:13","modified_gmt":"2025-05-11T17:41:13","slug":"psychiatric-comorbidities-following-mild-traumatic-brain-injury","status":"publish","type":"post","link":"https:\/\/beyondtheimpact.net\/?p=2406","title":{"rendered":"Psychiatric comorbidities following mild traumatic brain injury"},"content":{"rendered":"
    \n
  1. Epidemiology of psychiatric outcomes<\/a><\/li>\n
  2. Mechanisms of injury and neurobiological impact<\/a><\/li>\n
  3. Common psychiatric comorbidities post-mTBI<\/a><\/li>\n
  4. Assessment and diagnostic considerations<\/a><\/li>\n
  5. Treatment approaches and long-term management<\/a><\/li>\n<\/ol>\n

    <\/a><\/p>\n

    The epidemiological landscape of psychiatric outcomes following mild traumatic brain injury (mTBI) reveals a complex and often under-recognised burden. Although mTBI is considered the least severe form of traumatic brain injury, a notable proportion of patients experience persistent psychiatric symptoms, particularly within the first year post-injury. Epidemiological studies have consistently identified elevated rates of depression, anxiety, post-traumatic stress disorder (PTSD), and other psychiatric disorders among individuals with mTBI compared to the general population and individuals with orthopaedic injuries.<\/p>\n

    Research suggests that approximately 15\u201330% of individuals with mTBI develop persistent post-concussion symptoms (PCS), which often encompass emotional and cognitive disturbances. Depression is among the most frequently reported psychiatric sequelae, with prevalence rates varying depending on study methods, populations, and time since injury but can range from 18% to over 35% within the first six months. PTSD has also been reported in up to 25% of those who suffer an mTBI, especially in cases where the injury was associated with a traumatic or life-threatening event, such as in military personnel or victims of assault or motor vehicle accidents.<\/p>\n

    Furthermore, comorbidity is common, with multiple psychiatric conditions frequently overlapping in mTBI populations. For example, anxiety disorders may coexist with depression or PTSD, complicating diagnosis and management. Large cohort studies and meta-analyses have highlighted that psychological symptoms can persist beyond the acute recovery period and may become chronic in a subset of patients. Adolescents, women, and individuals with pre-existing mental health conditions appear particularly vulnerable.<\/p>\n

    Importantly, epidemiological findings also underscore disparities in help-seeking behaviours and access to mental health services post-mTBI, with underdiagnosis and undertreatment remaining significant barriers. This gap in care accentuates the need for improved surveillance and early intervention strategies to address the psychiatric consequences commonly associated with mTBI.<\/p>\n

    Mechanisms of injury and neurobiological impact<\/h3>\n

    The neurobiological impact of mild traumatic brain injury (mTBI) is characterised by a range of structural and functional disruptions that contribute to the development of psychiatric comorbidities. Although mTBI is traditionally associated with transient symptoms, emerging evidence demonstrates that the injury can initiate complex cascades of neurochemical and cellular events which may underlie persistent problems, such as depression, anxiety, and post-traumatic stress disorder (PTSD). A key factor distinguishing mTBI from more severe forms of brain injury is that standard neuroimaging techniques often fail to detect overt brain damage, leading to underestimation of the physiological consequences that may nonetheless exert a profound influence on mental health.<\/p>\n

    Mechanistically, mTBI commonly results from biomechanical forces\u2014such as direct impact or rapid acceleration-deceleration\u2014that cause diffuse axonal injury (DAI), even in the absence of overt lesions. DAI involves the shearing of white matter tracts, disrupting connectivity across critical brain networks including those that regulate mood, affect, and executive function. Regions such as the prefrontal cortex, hippocampus, and amygdala are particularly susceptible, with aberrant functioning in these areas implicated in the pathophysiology of depression and PTSD. Disruption of the hypothalamic-pituitary-adrenal (HPA) axis is also observed following mTBI, leading to maladaptive stress responses that can heighten vulnerability to psychiatric disorders.<\/p>\n

    At the cellular level, mTBI triggers excitotoxicity through excessive glutamate release, leading to calcium influx and oxidative stress, which in turn can compromise neuronal integrity. Additionally, neuroinflammation plays a significant role; activation of microglia and astrocytes following injury results in the release of pro-inflammatory cytokines which may persist over time and have been linked to the development of mood disorders. These inflammatory processes are thought to influence neurogenesis and synaptic plasticity, thereby contributing to sustained emotional and cognitive disturbances associated with PCS.<\/p>\n

    There is also increasing recognition that disturbances in neurochemical pathways following mTBI\u2014such as serotonergic, dopaminergic, and noradrenergic systems\u2014may contribute to the onset of psychiatric symptoms. For example, reduced serotonergic transmission has been linked to depression, while dysregulation in dopamine pathways may underpin cognitive deficits and emotional dysregulation. These neurochemical imbalances, coupled with structural disconnection and persistent inflammation, provide a plausible basis for the characteristic symptomatology seen in individuals experiencing anxiety and depression post-mTBI.<\/p>\n

    Furthermore, genetic and epigenetic factors may modulate individual vulnerability to psychiatric sequelae after mTBI. Polymorphisms in genes involved in serotonin transport, neuroplasticity, and inflammatory response have been associated with poorer emotional outcomes. Moreover, repeated mTBIs\u2014commonly seen in contact sports and military settings\u2014are particularly associated with cumulative neural insult and an increased risk of chronic traumatic encephalopathy (CTE), a condition that has been linked to mood disturbances, aggression, and suicidal ideation.<\/p>\n

    The complex interplay between biomechanical injury, neuroinflammatory cascades, disrupted neural connectivity, and altered neurotransmitter functioning underscores the intricate neurobiological foundation of psychiatric comorbidities following mTBI. Understanding these mechanisms is essential for developing targeted strategies to mitigate long-term outcomes and improve the mental health trajectory of affected individuals.<\/p>\n

    Common psychiatric comorbidities post-mTBI<\/h3>\n

    Following mild traumatic brain injury (mTBI), a wide spectrum of psychiatric conditions may arise, with depression, anxiety, and post-traumatic stress disorder (PTSD) among the most common comorbidities. These disorders can emerge in both the acute and chronic phases post-injury, and their presentation is often influenced by factors such as injury severity, personal history, and situational context. Notably, psychiatric symptoms are not always immediately apparent and may be overshadowed initially by physical complaints, often delaying diagnosis and intervention.<\/p>\n

    Depression is one of the most frequently observed conditions following mTBI, with patients often reporting persistent low mood, anhedonia, fatigue, and cognitive slowing. The onset of depressive symptoms may be linked to structural and functional brain alterations, particularly in the frontal and limbic systems, and is frequently accompanied by impairments in daily functioning and social withdrawal. Moreover, the overlap between depression and post-concussion symptoms (PCS), such as sleep disruptions, concentration difficulties, and irritability, complicates the clinical picture and can obscure accurate diagnosis.<\/p>\n

    Anxiety disorders, including generalised anxiety disorder and panic disorder, are also prevalent among individuals with mTBI. These conditions may be exacerbated by the neurochemical and physiological responses to injury, as well as by the individual’s psychosocial circumstances. Increased sensitivity to stimuli, hypervigilance, and anticipatory anxiety are common, particularly in patients who experience PCS. Anxiety can also co-occur with depression and PTSD, adding to the overall symptom burden.<\/p>\n

    PTSD is a particularly common psychiatric outcome when mTBI is sustained in traumatic contexts, such as combat exposure, motor vehicle collisions, or interpersonal violence. The core symptoms of PTSD\u2014re-experiencing, avoidance, negative cognitions, and heightened arousal\u2014may be magnified by cognitive impairments resulting from the brain injury. Importantly, PTSD following mTBI is not restricted to individuals with loss of consciousness; even subconcussive impacts have been linked to trauma-related symptoms, suggesting that psychological trauma and physical injury independently and interactively contribute to symptom development.<\/p>\n

    Other psychiatric disorders, such as adjustment disorders, substance use disorders, and sleep-wake disturbances, are also documented in people experiencing mTBI. Sleep disturbances, in particular, are both a symptom of PCS and a risk factor for mood dysregulation, further compounding psychiatric vulnerability. Furthermore, substance misuse may represent a maladaptive coping mechanism for managing emotional distress or cognitive deficits associated with mTBI, and in some cases, may precede the injury and increase the risk of adverse outcomes.<\/p>\n

    Comorbidity among these psychiatric conditions is common, with patients often meeting criteria for multiple diagnoses simultaneously. This convergence contributes to complexity in symptom presentation and can hinder effective treatment. For instance, overlapping features between depression and PTSD may affect treatment response and necessitate tailored therapeutic strategies. Moreover, the impact of these disorders extends beyond mental health, influencing occupational participation, interpersonal relationships, and overall quality of life.<\/p>\n

    Children and adolescents with mTBI are particularly susceptible to psychiatric sequelae due to ongoing brain development and heightened emotional sensitivity. In this younger population, symptoms may manifest as behavioural changes, academic decline, or social difficulties rather than explicit verbalisation of depressive or anxious thoughts. Similarly, individuals with a prior history of psychiatric illness are at heightened risk for symptom exacerbation or recurrence post-injury, underscoring the importance of pre-injury mental health as a predictive factor.<\/p>\n

    Collectively, these findings highlight that psychiatric comorbidities following mTBI are neither rare nor transient, and they demand careful clinical attention. Beyond the biological underpinnings explored in previous sections, the lived experience of mTBI\u2014including loss of identity, reduced independence, and social isolation\u2014further compounds emotional distress and interferes with recovery. Addressing these complex psychiatric presentations requires a nuanced understanding of their multifactorial aetiology and a commitment to integrated and sustained intervention approaches.<\/p>\n

    Assessment and diagnostic considerations<\/h3>\n

    Accurate assessment of psychiatric comorbidities following mild traumatic brain injury (mTBI) is a critical step in ensuring timely and appropriate intervention. The diagnostic process is challenged by overlapping symptomatology between mTBI and various psychiatric disorders, particularly when post-concussion symptoms (PCS) include cognitive, emotional, and somatic manifestations that mirror those found in depression, anxiety, and PTSD. Clinicians must, therefore, employ a comprehensive, multidisciplinary approach that integrates clinical history, neuropsychological evaluation, structured interviews, and symptom-specific screening tools.<\/p>\n

    Initial assessment should include a detailed clinical interview encompassing the mechanism of injury, duration of loss of consciousness or amnesia, prior psychiatric history, and pre-existing medical conditions. Understanding the patient\u2019s psychological and social environment both prior to and following the injury is essential for contextualising their current presentation. Particular attention should be paid to the timeline of symptom onset, as psychiatric symptoms may be delayed and evolve over time, often becoming more apparent during the subacute or chronic phases of recovery.<\/p>\n

    Screening tools serve as valuable adjuncts in identifying at-risk individuals and facilitating early detection. Instruments such as the Patient Health Questionnaire-9 (PHQ-9) for depression, the Generalised Anxiety Disorder-7 (GAD-7) for anxiety, and the PTSD Checklist for DSM-5 (PCL-5) can provide quantitative insight into symptom severity and aid in monitoring over time. However, these tools should be interpreted with caution in mTBI populations to differentiate between primary psychiatric disorders and symptoms attributable to PCS. For instance, sleep disturbances or concentration issues may be mistakenly interpreted solely as signs of depression if the broader context of mTBI is not considered.<\/p>\n

    Neuropsychological testing is often employed to evaluate cognitive domains affected by mTBI, including attention, memory, processing speed, and executive functioning. While these assessments are not diagnostic of psychiatric illness per se, they provide objective data that can distinguish between cognitive impairment related to brain injury versus those linked to mood disorders. For example, psychomotor slowing and inattention may result directly from mTBI-related neuropathology or may be secondary to depression or anxiety.<\/p>\n

    More nuanced diagnostic clarification may require the involvement of mental health professionals with expertise in brain injury. Psychiatric assessments, possibly incorporating semi-structured interviews such as the Mini International Neuropsychiatric Interview (MINI) or the Structured Clinical Interview for DSM Disorders (SCID), can aid in distinguishing between overlapping clinical entities. Collaborating across disciplines ensures that both neurological and psychological aspects of mTBI are adequately addressed.<\/p>\n

    A further consideration in diagnostic evaluation is the potential influence of malingering or symptom exaggeration, particularly in medicolegal contexts. Validity testing, embedded within neuropsychological batteries, can assist in assessing effort and reliability of test results. Nonetheless, caution must be exercised to avoid invalidating genuine distress exhibited by individuals who may struggle to articulate the complexities of their cognitive and emotional symptoms.<\/p>\n

    In younger populations and those from diverse cultural backgrounds, assessment must be adapted to accommodate developmental stages, language barriers, and cultural conceptualisations of mental health. In children and adolescents, behavioural changes such as irritability, academic regression, or withdrawal from social activities may be indicative of underlying anxiety or depression following mTBI. Age-appropriate assessment tools and collateral information from parents, teachers, or caregivers are therefore crucial.<\/p>\n

    Re-assessment over time is essential, given the dynamic nature of symptom development following mTBI. Psychiatric symptoms may emerge or fluctuate across recovery, necessitating ongoing evaluation to detect delayed onset disorders or track progress. This longitudinal approach allows clinicians to discern whether residual symptoms reflect incomplete neurological recovery, psychological adjustment difficulties, or newly emergent psychiatric conditions.<\/p>\n

    Ultimately, careful assessment and diagnostic clarity are foundational for developing effective treatment strategies and improving outcomes for individuals coping with the mental health sequelae of mTBI. Given the interplay between PCS and psychiatric disorders such as depression, anxiety, and PTSD, ongoing vigilance and collaboration among clinicians are imperative to ensure these conditions are accurately identified and appropriately managed.<\/p>\n

    Treatment approaches and long-term management<\/h3>\n

    Treatment of psychiatric comorbidities following mild traumatic brain injury (mTBI) necessitates a multidisciplinary and individualised approach, recognising the intersection of neurological injury with psychological and social factors. Due to the overlap between post-concussion symptoms (PCS) and psychiatric manifestations such as depression, anxiety, and PTSD, effective management must integrate both pharmacological and non-pharmacological strategies, often delivered in tandem across specialties.<\/p>\n

    Pharmacological treatment plays a central role for many patients, particularly where symptoms are persistent or significantly impair functioning. Selective serotonin reuptake inhibitors (SSRIs) are commonly prescribed as first-line agents for depression and anxiety disorders in the post-mTBI population, supported by evidence of efficacy and tolerability. Other classes of antidepressants, such as serotonin-norepinephrine reuptake inhibitors (SNRIs), may also be considered, especially in cases where chronic pain or fatigue co-exist with mood symptoms. However, care must be taken to monitor for side effects that may exacerbate cognitive symptoms, particularly in the early phases of recovery.<\/p>\n

    In individuals with PTSD, medication may be beneficial as an adjunct to psychotherapy, with SSRIs again representing a mainstay of treatment. Where hyperarousal and sleep disturbances are prominent, short-term use of sedating agents, such as prazosin for nightmares or low-dose antipsychotics, may be warranted. Caution is necessary to avoid polypharmacy or use of medications that worsen concentration, memory, or fatigability, all common complaints in both PCS and psychiatric conditions. Regular medication reviews should form part of long-term management to ensure appropriate dosing and therapeutic response.<\/p>\n

    Psychological therapies are critical components of treatment, particularly in helping patients address the cognitive and emotional challenges related to mTBI. Cognitive behavioural therapy (CBT) has robust support in the treatment of depression, anxiety, and PTSD, and has been effectively adapted for individuals with brain injury. CBT can address maladaptive thought patterns concerning the injury, identity loss, and fears around recovery or future functioning. In cases involving PTSD, trauma-focused interventions such as prolonged exposure therapy or eye movement desensitisation and reprocessing (EMDR) may be appropriate, provided practitioners have expertise in managing co-occurring cognitive deficits.<\/p>\n

    Rehabilitation programmes that incorporate neuropsychological input alongside mental health support are particularly beneficial in cases where psychiatric symptoms are intertwined with significant PCS. These programmes may include targeted cognitive rehabilitation, psychoeducation about brain injury, and vocational counselling. The interdisciplinary nature of such approaches ensures that the individual is supported holistically, with close monitoring for changes in mood, cognition, and daily functioning. Tailoring interventions to the patient\u2019s specific symptom profile and life context is essential for achieving optimal outcomes.<\/p>\n

    Social support and environmental modifications also play substantial roles in helping patients reintegrate into work, education, and community life after mTBI. Occupational therapists, social workers, and case managers can assist in navigating social barriers, accessing benefits and resources, and promoting adaptive routines that mitigate the impact of persistent symptoms. Participation in peer-led support groups can provide emotional validation and practical coping strategies, reducing isolation and enhancing resilience.<\/p>\n

    Long-term management requires continued engagement, as psychiatric symptoms may relapse or evolve with time. Follow-up appointments should focus not only on symptom monitoring but also on prevention of secondary complications such as substance misuse, relationship breakdown, and unemployment. In some cases, family therapy can be instrumental in restoring interpersonal functioning and improving the understanding of mTBI-related changes, especially when behavioural or personality shifts are a concern.<\/p>\n

    For individuals with complex presentations\u2014such as co-occurring depression, PTSD, and prolonged PCS\u2014a stepped care model may be employed, escalating treatment intensity based on response. Specialist brain injury services may offer intensive outpatient programmes or referrals to tertiary centres for refractory cases. Multimodal treatment plans built around shared decision-making and continuity of care are key to addressing the multifaceted challenges these patients face.<\/p>\n

    Ongoing research into novel interventions, including mindfulness-based therapies, virtual reality-assisted exposure therapy for PTSD, and neuromodulation techniques such as transcranial magnetic stimulation (TMS), holds promise for expanding the treatment toolkit for mTBI-related psychiatric disorders. However, these approaches require further validation and should currently be considered within the context of clinical trials or specialist supervision.<\/p>\n

    Ultimately, the success of any treatment approach rests upon early identification, individualised planning, and sustained multidisciplinary collaboration. Given the complexity and chronicity of psychiatric comorbidities after mTBI, long-term management must be adaptive and inclusive, addressing not only symptom reduction but also recovery of identity, autonomy, and quality of life.<\/p>\n","protected":false},"excerpt":{"rendered":"

    Epidemiology of psychiatric outcomes Mechanisms of injury and neurobiological impact Common psychiatric comorbidities post-mTBI Assessment…<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[26,15],"tags":[210,215,19,21,546],"class_list":["post-2406","post","type-post","status-publish","format-standard","hentry","category-medical-professionals","category-traumatic-brain-injury","tag-anxiety","tag-depression","tag-mtbi","tag-pcs","tag-ptsd"],"yoast_head":"\nDepression and Anxiety After mTBI: Psychiatric Outcomes Explained<\/title>\n<meta name=\"description\" content=\"Examines how mTBI and PCS lead to depression, anxiety, and PTSD, with insights on psychiatric assessment, treatment, and long-term management.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/beyondtheimpact.net\/?p=2406\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Depression and Anxiety After mTBI: Psychiatric Outcomes Explained\" \/>\n<meta property=\"og:description\" content=\"Examines how mTBI and PCS lead to depression, anxiety, and PTSD, with insights on psychiatric assessment, treatment, and long-term management.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/beyondtheimpact.net\/?p=2406\" \/>\n<meta property=\"og:site_name\" content=\"Beyond the Impact\" \/>\n<meta property=\"article:published_time\" content=\"2025-05-11T17:41:13+00:00\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"14 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/beyondtheimpact.net\/?p=2406#article\",\"isPartOf\":{\"@id\":\"https:\/\/beyondtheimpact.net\/?p=2406\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/beyondtheimpact.net\/#\/schema\/person\/a5cf96dc27c4690dbf266a6cae4ee9aa\"},\"headline\":\"Psychiatric comorbidities following mild traumatic brain injury\",\"datePublished\":\"2025-05-11T17:41:13+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/beyondtheimpact.net\/?p=2406\"},\"wordCount\":2745,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/beyondtheimpact.net\/#organization\"},\"keywords\":[\"anxiety\",\"depression\",\"mTBI\",\"PCS\",\"PTSD\"],\"articleSection\":[\"Medical professionals\",\"Traumatic brain injury\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/beyondtheimpact.net\/?p=2406#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/beyondtheimpact.net\/?p=2406\",\"url\":\"https:\/\/beyondtheimpact.net\/?p=2406\",\"name\":\"Depression and Anxiety After mTBI: Psychiatric Outcomes Explained\",\"isPartOf\":{\"@id\":\"https:\/\/beyondtheimpact.net\/#website\"},\"datePublished\":\"2025-05-11T17:41:13+00:00\",\"description\":\"Examines how mTBI and PCS lead to depression, anxiety, and PTSD, with insights on psychiatric assessment, treatment, and long-term management.\",\"breadcrumb\":{\"@id\":\"https:\/\/beyondtheimpact.net\/?p=2406#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/beyondtheimpact.net\/?p=2406\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/beyondtheimpact.net\/?p=2406#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/beyondtheimpact.net\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Psychiatric comorbidities following mild traumatic brain injury\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/beyondtheimpact.net\/#website\",\"url\":\"https:\/\/beyondtheimpact.net\/\",\"name\":\"BeyondTheImpact\",\"description\":\"Concussion, FND and Neuroscience\",\"publisher\":{\"@id\":\"https:\/\/beyondtheimpact.net\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/beyondtheimpact.net\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/beyondtheimpact.net\/#organization\",\"name\":\"Beyond the Impact\",\"url\":\"https:\/\/beyondtheimpact.net\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/beyondtheimpact.net\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/beyondtheimpact.net\/wp-content\/uploads\/2025\/04\/955D378D-9439-4958-AA9D-866B66877DCB-1.png\",\"contentUrl\":\"https:\/\/beyondtheimpact.net\/wp-content\/uploads\/2025\/04\/955D378D-9439-4958-AA9D-866B66877DCB-1.png\",\"width\":1024,\"height\":1024,\"caption\":\"Beyond the Impact\"},\"image\":{\"@id\":\"https:\/\/beyondtheimpact.net\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/beyondtheimpact.net\/#\/schema\/person\/a5cf96dc27c4690dbf266a6cae4ee9aa\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/beyondtheimpact.net\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/59867129c03db343d7fdc6272ec5e0a85250cd376a4e7153307728ae82a1b108?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/59867129c03db343d7fdc6272ec5e0a85250cd376a4e7153307728ae82a1b108?s=96&d=mm&r=g\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/beyondtheimpact.net\"],\"url\":\"https:\/\/beyondtheimpact.net\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Depression and Anxiety After mTBI: Psychiatric Outcomes Explained","description":"Examines how mTBI and PCS lead to depression, anxiety, and PTSD, with insights on psychiatric assessment, treatment, and long-term management.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/beyondtheimpact.net\/?p=2406","og_locale":"en_US","og_type":"article","og_title":"Depression and Anxiety After mTBI: Psychiatric Outcomes Explained","og_description":"Examines how mTBI and PCS lead to depression, anxiety, and PTSD, with insights on psychiatric assessment, treatment, and long-term management.","og_url":"https:\/\/beyondtheimpact.net\/?p=2406","og_site_name":"Beyond the Impact","article_published_time":"2025-05-11T17:41:13+00:00","author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"14 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/beyondtheimpact.net\/?p=2406#article","isPartOf":{"@id":"https:\/\/beyondtheimpact.net\/?p=2406"},"author":{"name":"admin","@id":"https:\/\/beyondtheimpact.net\/#\/schema\/person\/a5cf96dc27c4690dbf266a6cae4ee9aa"},"headline":"Psychiatric comorbidities following mild traumatic brain injury","datePublished":"2025-05-11T17:41:13+00:00","mainEntityOfPage":{"@id":"https:\/\/beyondtheimpact.net\/?p=2406"},"wordCount":2745,"commentCount":0,"publisher":{"@id":"https:\/\/beyondtheimpact.net\/#organization"},"keywords":["anxiety","depression","mTBI","PCS","PTSD"],"articleSection":["Medical professionals","Traumatic brain injury"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/beyondtheimpact.net\/?p=2406#respond"]}]},{"@type":"WebPage","@id":"https:\/\/beyondtheimpact.net\/?p=2406","url":"https:\/\/beyondtheimpact.net\/?p=2406","name":"Depression and Anxiety After mTBI: Psychiatric Outcomes Explained","isPartOf":{"@id":"https:\/\/beyondtheimpact.net\/#website"},"datePublished":"2025-05-11T17:41:13+00:00","description":"Examines how mTBI and PCS lead to depression, anxiety, and PTSD, with insights on psychiatric assessment, treatment, and long-term management.","breadcrumb":{"@id":"https:\/\/beyondtheimpact.net\/?p=2406#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/beyondtheimpact.net\/?p=2406"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/beyondtheimpact.net\/?p=2406#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/beyondtheimpact.net\/"},{"@type":"ListItem","position":2,"name":"Psychiatric comorbidities following mild traumatic brain injury"}]},{"@type":"WebSite","@id":"https:\/\/beyondtheimpact.net\/#website","url":"https:\/\/beyondtheimpact.net\/","name":"BeyondTheImpact","description":"Concussion, FND and Neuroscience","publisher":{"@id":"https:\/\/beyondtheimpact.net\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/beyondtheimpact.net\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/beyondtheimpact.net\/#organization","name":"Beyond the Impact","url":"https:\/\/beyondtheimpact.net\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/beyondtheimpact.net\/#\/schema\/logo\/image\/","url":"https:\/\/beyondtheimpact.net\/wp-content\/uploads\/2025\/04\/955D378D-9439-4958-AA9D-866B66877DCB-1.png","contentUrl":"https:\/\/beyondtheimpact.net\/wp-content\/uploads\/2025\/04\/955D378D-9439-4958-AA9D-866B66877DCB-1.png","width":1024,"height":1024,"caption":"Beyond the Impact"},"image":{"@id":"https:\/\/beyondtheimpact.net\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/beyondtheimpact.net\/#\/schema\/person\/a5cf96dc27c4690dbf266a6cae4ee9aa","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/beyondtheimpact.net\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/59867129c03db343d7fdc6272ec5e0a85250cd376a4e7153307728ae82a1b108?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/59867129c03db343d7fdc6272ec5e0a85250cd376a4e7153307728ae82a1b108?s=96&d=mm&r=g","caption":"admin"},"sameAs":["https:\/\/beyondtheimpact.net"],"url":"https:\/\/beyondtheimpact.net\/?author=1"}]}},"_links":{"self":[{"href":"https:\/\/beyondtheimpact.net\/index.php?rest_route=\/wp\/v2\/posts\/2406","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/beyondtheimpact.net\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/beyondtheimpact.net\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/beyondtheimpact.net\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/beyondtheimpact.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2406"}],"version-history":[{"count":0,"href":"https:\/\/beyondtheimpact.net\/index.php?rest_route=\/wp\/v2\/posts\/2406\/revisions"}],"wp:attachment":[{"href":"https:\/\/beyondtheimpact.net\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2406"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/beyondtheimpact.net\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=2406"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/beyondtheimpact.net\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=2406"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}